Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

BACKGROUND AND OBJECTIVE: Systemic inflammation response index (SIRI=N×M/L), based on neutrophil (N), monocyte (M), and lymphocyte (L) counts, is used to predict the survival of patients with malignant tumors and can fully evaluate the balance between host immune and inflammatory condition. The pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li, Kong, Xiangyi, Wang, Zhongzhao, Wang, Xiangyu, Fang, Yi, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060771/
https://www.ncbi.nlm.nih.gov/pubmed/32184659
http://dx.doi.org/10.2147/CMAR.S235519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060771/
https://www.ncbi.nlm.nih.gov/pubmed/32184659
http://dx.doi.org/10.2147/CMAR.S235519

Ejemplares similares